ArticleMedicina oral, patologia oral y cirugia bucal2026
Return to work and its determinants among head and neck cancer survivors: a cross-sectional study.
Article in Medicina oral, patologia oral y cirugia bucal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundReturn to work is an important marker of rehabilitation. While many head and neck cancer survivors are motivated to resume work, they often face greater disability and reintegration challenges than other cancer survivors due to clinical and psychosocial factors. The objective of this study was to identify determinants of return to work and to explore barriers and facilitators to workforce reintegration among head and neck cancer survivors. MATERIAL AND
methodsThis cross-sectional study of 215 head and neck cancer survivors at two stomatology services used questionnaires to assess socioeconomic, clinical, illness-related, employment, and psychosocial factors. The statistical analysis evaluated correlations with return to work.
resultsAmong 215 participants, 137 (63.7%) returned to work. Smaller tumors (p < 0.0001), no lymph node (p = 0.0076), or distant metastases (p = 0.0122) positively influenced reintegration. Radiotherapy (p = 0.0005) and chemotherapy (p = 0.0001) negatively impacted. Completing treatment within six months improved reintegration (67.5%; p = 0.0004), while tracheostomy reduced it (12.5%; p = 0.0021). Neck hypersensitivity (p = 0.0009), paresthesia with incomplete eye closure (p = 0.0027), paresthesia of the corner of the mouth (p = 0.0098) and functional restrictions hindered reintegration. White-collar workers (75.0%) returned more often. Returning survivors had higher anxiety (69.3%; p = 0.0366), quality of life (89.1%; p < 0.0001), higher income (p = 0.0022), and education (p = 0.0110).
conclusionsSocioeconomic status, education level, tumor characteristics, and treatment modalities significantly affect return to work rates. Physical and functional impairments, along with differences in occupational categories, further hinder reintegration, underscoring the importance of tailored strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.